"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 4 | 1 | 5 |
| 2013 | 4 | 2 | 6 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 5 | 7 |
| 2016 | 4 | 2 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 5 | 1 | 6 |
| 2019 | 5 | 2 | 7 |
| 2020 | 6 | 1 | 7 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 7 | 7 |
| 2023 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment. Sci Transl Med. 2023 07 19; 15(705):eadg1659.
-
Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients. Clin Breast Cancer. 2023 08; 23(6):e345-e353.
-
Activation of ?-adrenergic receptor signaling prevents glucocorticoid-induced obesity and adipose tissue dysfunction in male mice. Am J Physiol Endocrinol Metab. 2023 06 01; 324(6):E514-E530.
-
Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function. Int J Obes (Lond). 2023 06; 47(6):505-511.
-
Perinatal Obesity Sensitizes for Premature Kidney Aging Signaling. Int J Mol Sci. 2023 Jan 28; 24(3).
-
Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease. J Hepatol. 2022 12; 77(6):1504-1514.
-
Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium. Cardiovasc Diabetol. 2022 06 09; 21(1):99.
-
Differential Effects of Obesity, Hyperlipidaemia, Dietary Intake and Physical Inactivity on Type I versus Type IV Allergies. Nutrients. 2022 Jun 05; 14(11).
-
Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice. Int J Mol Sci. 2022 May 17; 23(10).
-
Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study. Int J Obes (Lond). 2022 07; 46(7):1366-1374.
MeSH information
